Daily Archives: August 23, 2021

The Australian Financial Review: Clarity Pharmaceuticals to hit ASX in August

Sydney, Australia, 21 July 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Australian daily newspaper covering the latest business and economic affairs of Australia and the world. The article discusses Clarity, our history, clinical trials, technology and the initial public offering on the Australian Securities Exchange. Read the full article here: https://www.afr.com/companies/healthcare-and-fitness/clarity-pharmaceuticals-to-hit-asx-in-august-20210720-p58b98

The Australian Financial Review: Terms out for Clarity’s $358m IPO

Sydney, Australia, 12 July 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Street Talk, the leading source of breaking news in Australia’s capital markets with live updates throughout the trading day. The article discusses the terms of Clarity’s initial public offering on the Australian Securities Exchange. Read the full article here: https://www.afr.com/street-talk/terms-out-for-clarity-s-358m-ipo-20210712-p588tj

The Australian: Clarity embarks on cornerstone process for IPO

Sydney, Australia, 8 July 2021 – Clarity Pharmaceuticals was featured in the Australian, Australia’s national broadsheet newspaper published by News Corp Australia since 14 July 1964. The article discusses Clarity’s initial public offering on the Australian Securities Exchange. Read the full article here: https://www.theaustralian.com.au/business/dataroom/clarity-pharmaceuticals-embarks-on-cornerstone-process-for-ipo/news-story/b2824850cb8686e039e68aecb9fafca2

The Australian Financial Review: Sirtex buyer China Grand looks to bankroll IPO candidate Clarity

Sydney, Australia, 8 July 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Street Talk, the leading source of breaking news in Australia’s capital markets with live updates throughout the trading day. The article discusses Clarity’s initial public offering on the Australian Securities Exchange and option agreement with China Grand Pharmaceuticals and Healthcare.…

The Australian Financial Review: Jefferies, Bells prepare cancer play Clarity for $300m float

Sydney, Australia 8 June 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Street Talk, the leading source of breaking news in Australia’s capital markets with live updates throughout the trading day. The article discusses Clarity’s initial public offering on the Australian Securities Exchange. Read the full article here: https://www.afr.com/street-talk/jefferies-bells-prepare-cancer-play-clarity-for-250m-float-20210608-p57z40